Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Ascendis Pharma A (ASND) over the last 6 years, with Q3 2025 value amounting to 487.51%.

  • Ascendis Pharma A's Return on Invested Capital rose 4880500.0% to 487.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 487.51%, marking a year-over-year increase of 4880500.0%. This contributed to the annual value of 0.44% for FY2024, which is 3100.0% up from last year.
  • Ascendis Pharma A's Return on Invested Capital amounted to 487.51% in Q3 2025, which was up 4880500.0% from 528.72% recorded in Q2 2025.
  • Ascendis Pharma A's Return on Invested Capital's 5-year high stood at 547.51% during Q4 2024, with a 5-year trough of 3.48% in Q2 2023.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.55% (2021), whereas its average is 108.89%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -28400bps in 2023, then soared by 5486500bps in 2024.
  • Ascendis Pharma A's Return on Invested Capital (Quarter) stood at 0.46% in 2021, then tumbled by -83bps to 0.85% in 2022, then crashed by -34bps to 1.14% in 2023, then surged by 48160bps to 547.51% in 2024, then fell by -11bps to 487.51% in 2025.
  • Its Return on Invested Capital stands at 487.51% for Q3 2025, versus 528.72% for Q2 2025 and 520.15% for Q1 2025.